Alkeran (Melphalan) in the treatment of myelomatosis.
D000328:Adult; D000368:Aged; D001792:Blood Platelets; D001798:Blood Proteins; D003401:Creatine; D005260:Female; D006801:Humans; D006934:Hypercalcemia; D066298:In Vitro Techniques; D007962:Leukocytes; D008297:Male; D008558:Melphalan / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use; D011507:Proteinuria
D001798:Blood Proteins; D003401:Creatine; D008558:Melphalan; D011241:Prednisone